Impacts of the prostate stem cell antigen (PSCA) and Clostridium perfringens enterotoxin (CPE) on the apoptosis and cell cycle regulatory genes in PC3

References

• Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2018. CA: A Cancer J. Clin. 2018, 68, 7–30.
   PubMed Web of Science ®Google Scholar
• Baade, P. D.; Youlden, D. R.; Cramb, S. M.; Dunn, J.; Gardiner, R. A. Epidemiology of Prostate Cancer in the Asia-Pacific Region. Prostate Int. 2013, 1, 47–58.
   PubMedGoogle Scholar
• Nauts, H. The Beneficial Effects of Bacterial Infections on Host Resistance to Cancer. End Results in 449 cases. A Study and Abstracts of Reports in the World Medical Literature (1775–1980) and Personal Communications; Cancer Research Institute: New York, 1980.
   Google Scholar
• Pastan, I.; Hassan, R.; FitzGerald, D. J.; Kreitman, R. J. Immunotoxin Treatment of Cancer. Annu. Rev. Med. 2007, 58, 221–237.
   PubMed Web of Science ®Google Scholar
• Lorberboum-Galski, H. Human Toxin-Based Recombinant Immunotoxins/Chimeric Proteins as a Drug Delivery System for Targeted Treatment of Human Diseases. Expert Opin. Drug Deliv. 2011, 8, 605–621.
   PubMed Web of Science ®Google Scholar
• McCann, K. J.; Godeseth, R.; Chudley, L.; Mander, A.; Di Genova, G.; Lloyd-Evans, P.; Kerr, J. P.; Malykh, V. B.; Jenner, M. W.; Orchard, K. H.; et al. Idiotypic DNA Vaccination for the Treatment of Multiple Myeloma: safety and Immunogenicity in a Phase I Clinical Study. Cancer Immunol. Immunother. 2015, 64, 1021–1032.
   PubMed Web of Science ®Google Scholar
• Ryan, K. J.; Ray, C. G. Medical Microbiology. 4th ed.; McGraw Hill: New York, 2004; p. 370.
   Google Scholar
• Kiu, R.; Caim, S.; Alexander, S.; Pachori, P.; Hall, L. J. Probing Genomic Aspects of the Multi-Host Pathogen Clostridium perfringens Reveals Significant Pangenome Diversity, and a Diverse Array of Virulence Factors. Front. Microbiol. 2017, 8, 2485.
   PubMed Web of Science ®Google Scholar
• Kokai-Kun, J. F.; Songer, J. G.; Czeczulin, J. R.; Chen, F.; McClane, B. A. Comparison of Western Immunoblots and Gene Detection Assays for Identification of Potentially Enterotoxigenic Isolates of Clostridium perfringens. J. Clin. Microbiol. 1994, 32, 2533–2539.
   PubMed Web of Science ®Google Scholar
• Li, J.; Miyamoto, K.; Sayeed, S.; McClane, B. A. Organization of the Cpe Locus in CPE-Positive clostridium perfringens Type C and D Isolates. PLoS One. 2010, 5, e10932.
   PubMed Web of Science ®Google Scholar
• Czeczulin, J. R.; Hanna, P. C.; McClane, B. A. Cloning, Nucleotide Sequencing, and Expression of the Clostridium perfringens Enterotoxin Gene in Escherichia coli. Infect Immun. 1993, 61, 3429–3439.
   PubMed Web of Science ®Google Scholar
• Landers, K. A.; Samaratunga, H.; Teng, L.; Buck, M.; Burger, M. J.; Scells, B.; Lavin, M. F.; Gardiner, R. A. Identification of Claudin-4 as a Marker Highly Overexpressed in Both Primary and Metastatic Prostate Cancer. Br. J. Cancer 2008, 99, 491.
   PubMed Web of Science ®Google Scholar
• Maeda, T.; Murata, M.; Chiba, H.; Takasawa, A.; Tanaka, S.; Kojima, T.; Masumori, N.; Tsukamoto, T.; Sawada, N. Claudin‐4‐Targeted Therapy Using Clostridium perfringens Enterotoxin for Prostate Cancer. Prostate 2012, 72, 351–360.
   PubMed Web of Science ®Google Scholar
• Oliveira, S. S.; Morgado-Diaz, J. A. Claudins: Multifunctional Players in Epithelial Tight Junctions and Their Role in Cancer. Cell. Mol. Life Sci. 2007, 64, 17–28.
   PubMed Web of Science ®Google Scholar
• Reiter, R. E.; Gu, Z.; Watabe, T.; Thomas, G.; Szigeti, K.; Davis, E.; Wahl, M.; Nisitani, S.; Yamashiro, J.; Le Beau, M. M.; et al. Prostate Stem Cell Antigen: A Cell Surface Marker Overexpressed in Prostate Cancer. Proc. Natl. Acad. Sci. 1998, 95, 1735–1740.
   PubMed Web of Science ®Google Scholar
• Gu, Z.; Thomas, G.; Yamashiro, J.; Shintaku, I.; Dorey, F.; Raitano, A.; Witte, O.; Said, J.; Loda, M.; Reiter, R. Prostate Stem Cell Antigen (PSCA) Expression Increases with High Gleason Score, Advanced Stage and Bone Metastasis in Prostate Cancer. Oncogene 2000, 19, 1288.
   PubMed Web of Science ®Google Scholar
• de la Luz Garcia-Hernandez, M.; Gray, A.; Hubby, B.; Klinger, O. J.; Kast, W. M. Prostate Stem Cell Antigen Vaccination Induces a Long-Term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity. Cancer Res. 2008, 68, 861–869.
   PubMed Web of Science ®Google Scholar
• Gu, Z.; Yamashiro, J.; Kono, E.; Reiter, R. E. Anti–Prostate Stem Cell Antigen Monoclonal Antibody 1G8 Induces Cell Death in Vitro and Inhibits Tumor Growth in Vivo via a Fc-Independent Mechanism. Cancer Res. 2005, 65, 9495–9500.
   PubMed Web of Science ®Google Scholar
• Saffran, D. C.; Raitano, A. B.; Hubert, R. S.; Witte, O. N.; Reiter, R. E.; Jakobovits, A. Anti-PSCA mAbs Inhibit Tumor Growth and Metastasis Formation and Prolong the Survival of Mice Bearing Human Prostate Cancer Xenografts. Proc. Natl. Acad. Sci. 2001, 98, 2658–2663.
   PubMed Web of Science ®Google Scholar
• Sakamoto, H.; Yoshimura, K.; Saeki, N.; Katai, H.; Shimoda, T.; Matsuno, Y.; Saito, D.; Sugimura, H.; Tanioka, F.; Kato, S.; et al. Genetic Variation in PSCA Is Associated with Susceptibility to Diffuse-Type Gastric Cancer. Nat. Genet. 2008, 40, 730.
   PubMed Web of Science ®Google Scholar
• Keer, H. N.; Kozlowski, J. M.; Tsai, Y. C.; Lee, C.; McEwan, R. N.; Grayhack, J. T. Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed in Vitro and in Vivo. J. Urol. 1990, 143, 381–385.
   PubMed Web of Science ®Google Scholar
• Kaighn, M.; Narayan, K. S.; Ohnuki, Y.; Lechner, J.; Jones, L. Establishment and Characterization of a Human Prostatic Carcinoma Cell Line (PC-3). Invest. Urol. 1979, 17, 16–23.
   PubMedGoogle Scholar
• Kaighn, M. E.; Narayan, K. S.; Ohnuki, Y.; Lechner, J. F.; Jones, L. W. Establishment and Characterization of a Human Prostatic Carcinoma Cell Line (PC-3). Invest. Urol. 1979, 17, 16–23.
   PubMedGoogle Scholar
• Sambrook, J.; Russell, D. W. Molecular Cloning: A Laboratory Manual. Cold Spring Harb Lab Press, Cold Spring Harbor, NY, 2001; p. 999.
   Google Scholar
• Twentyman, P. R.; Luscombe, M. A Study of Some Variables in a Tetrazolium Dye (MTT) Based Assay for Cell Growth and Chemosensitivity. Br. J. Cancer 1987, 56, 279.
   PubMed Web of Science ®Google Scholar
• Yue, D.; Wang, Y.; Ma, P.; Li, Y.-Y.; Chen, H.; Wang, P.; Ren, C.-S. Effects of Transferred NK4 Gene on Proliferation, Migration, Invasion and Apoptosis of Human Prostate Cancer DU145 Cells. Asian J. Androl. 2010, 12, 381.
   PubMed Web of Science ®Google Scholar
• Chudley, L.; McCann, K.; Mander, A.; Tjelle, T.; Campos-Perez, J.; Godeseth, R.; Creak, A.; Dobbyn, J.; Johnson, B.; Bass, P.; et al. DNA Fusion-Gene Vaccination in Patients with Prostate Cancer Induces High-Frequency CD8+ T-Cell Responses and Increases PSA Doubling Time. Cancer Immunol. Immunother. 2012, 61, 2161–2170.
   PubMed Web of Science ®Google Scholar
• Bernardes, N.; Seruca, R.; Chakrabarty, A. M.; Fialho, A. M. Microbial-Based Therapy of Cancer: current Progress and Future Prospects. Bioeng. Bugs 2010, 1, 178–190.
   PubMedGoogle Scholar
• Hong, C. S.; Yamada, T.; Fialho, A. M.; Gupta, T. K. D.; Chakrabarty, A. M. Disrupting the Entry Barrier and Attacking Brain Tumors: The Role of the Neisseria Lipobox-Containing H. 8 Epitope and the Laz Protein. Cell Cycle 2006, 5, 1633–1641.
   PubMed Web of Science ®Google Scholar
• Punj, V.; Bhattacharyya, S.; Saint-Dic, D.; Vasu, C.; Cunningham, E. A.; Graves, J.; Yamada, T.; Constantinou, A. I.; Christov, K.; White, B.; et al. Bacterial Cupredoxin Azurin as an Inducer of Apoptosis and Regression in Human Breast Cancer. Oncogene 2004, 23, 2367.
   PubMed Web of Science ®Google Scholar
• Yamada, T.; Goto, M.; Punj, V.; Zaborina, O.; Chen, M. L.; Kimbara, K.; Majumdar, D.; Cunningham, E.; Gupta, T. K. D.; Chakrabarty, A. M. Bacterial Redox Protein Azurin, Tumor Suppressor Protein p53, and Regression of Cancer. Proc. Natl. Acad. Sci. 2002, 99, 14098–14103.
   PubMed Web of Science ®Google Scholar
• Yamada, T.; Hiraoka, Y.; Ikehata, M.; Kimbara, K.; Avner, B. S.; Gupta, T. K. D.; Chakrabarty, A. M. Apoptosis or Growth Arrest: Modulation of Tumor Suppressor p53’s Specificity by Bacterial Redox Protein Azurin. Proc. Natl. Acad. Sci. 2004, 101, 4770–4775.
   PubMed Web of Science ®Google Scholar
• Walther, W.; Petkov, S.; Kuvardina, O. N.; Aumann, J.; Kobelt, D.; Fichtner, I.; Lemm, M.; Piontek, J.; Blasig, I. E.; Stein, U.; Schlag, P. M. Novel Clostridium perfringens Enterotoxin Suicide Gene Therapy for Selective Treatment of Claudin-3-and-4-Overexpressing Tumors. Gene Ther. 2012, 19, 494.
   PubMed Web of Science ®Google Scholar
• Gao, Z.; McClane, B. A. Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: opportunities and Challenges. J. Toxicol. 2012, 2012, 1.
   Google Scholar
• Pahle, J.; Menzel, L.; Niesler, N.; Kobelt, D.; Aumann, J.; Rivera, M.; Walther, W. Rapid Eradication of Colon Carcinoma by Clostridium perfringens Enterotoxin Suicidal Gene Therapy. BMC Cancer 2017, 17, 129.
   PubMed Web of Science ®Google Scholar
• Gajate, C.; Mollinedo, F. Cytoskeleton-Mediated Death Receptor and Ligand Concentration in Lipid Rafts Forms Apoptosis-Promoting Clusters in Cancer Chemotherapy. J. Biol. Chem. 2005, 280, 11641–11647.
   PubMed Web of Science ®Google Scholar
• Purvis, J. E.; Karhohs, K. W.; Mock, C.; Batchelor, E.; Loewer, A.; Lahav, G. p53 Dynamics Control Cell Fate. Science. 2012, 336, 1440–1444.
   PubMed Web of Science ®Google Scholar
• Westphal, D.; Kluck, R.; Dewson, G. Building Blocks of the Apoptotic Pore: How Bax and Bak Are Activated and Oligomerize during Apoptosis. Cell Death Differ. 2014, 21, 196.
   PubMed Web of Science ®Google Scholar
• Diehl, J. A. Cycling to Cancer with Cyclin D1. Cancer Biol. Ther. 2002, 1, 226–231.
   PubMed Web of Science ®Google Scholar
• Shintani, M.; Okazaki, A.; Masuda, T.; Kawada, M.; Ishizuka, M.; Doki, Y.; Weinstein, I. B.; Imoto, M. Overexpression of Cyclin DI Contributes to Malignant Properties of Esophageal Tumor Cells by Increasing VEGF Production and Decreasing Fas Expression. Anticancer Res. 2002, 22, 639–647.
   PubMed Web of Science ®Google Scholar
• Kossatz, U.; Breuhahn, K.; Wolf, B.; Hardtke-Wolenski, M.; Wilkens, L.; Steinemann, D.; Singer, S.; Brass, F.; Kubicka, S.; Schlegelberger, B.; et al. The Cyclin E Regulator Cullin 3 Prevents Mouse Hepatic Progenitor Cells from Becoming Tumor-Initiating Cells. J. Clin. Invest. 2010, 120, 3820–3833.
   PubMed Web of Science ®Google Scholar
• Narges Abdian, P. G.-D.; Hashemzadeh-Chaleshtori, M.; Ganji-Arjenaki, M.; Doosti, A.; Amiri, B. Comparison of Human Dermal Fibroblasts (HDFs) Growth Rate in Culture Media Supplemented with or without Basic Fibroblast Growth Factor (bFGF). Cell Tissue Bank. 2015, 14, 487–495.
   Google Scholar